Latest Balance Sheet News

ALS Limited has completed a significant institutional placement, issuing over 20.9 million shares at A$16.70 each, bolstering its capital base without the need for full disclosure under the Corporations Act.

Excite Technology Services reported a strong 53% revenue increase to $12.27 million for FY2025 but also saw its net loss nearly double to $4.44 million. The company expanded its footprint with the acquisition of digital forensics specialist CBIT Pty Ltd.

Amplia Therapeutics reports strong progress in its pancreatic cancer drug development, completing the ACCENT trial recruitment ahead of schedule and initiating a new US trial, while managing a $6.57 million loss for FY25.

Little Green Pharma Ltd has reported a robust turnaround for FY2025, posting a $3.3 million profit after tax on revenues up 43%, driven by strong growth in Australia and Europe and strategic acquisitions.

DXN Limited has completed the purchase of the Secure Data Centre Darwin property, backed by a $5 million refinancing that reduces debt and boosts cash flow by $266,000 annually.

Cann Group Limited has reported a strong operational update, exceeding its medicinal cannabis production targets and significantly reducing costs, while expanding sales channels and securing fresh capital to bolster its balance sheet.

F.F.I. Holdings Ltd anticipates a substantial uplift in its property valuations as of June 2025, driven by rising asset values in both investment and own-use properties.

Findi Limited has reported record FY25 financial results, exceeding revenue guidance and expanding its ATM and digital financial services footprint across India. The company is advancing towards a Payments Bank license and plans an IPO of its Indian subsidiary by the end of 2026.

Findi Limited has reported record FY25 revenue and EBITDA growth, driven by key acquisitions and expanded ATM and digital payment networks across India. The company’s strengthened balance sheet and contract wins set the stage for its subsidiary’s planned 2026 IPO.

Findi Ltd reports flat revenue and a 15% rise in EBITDA but swings to a $12.5 million net loss for FY2025, driven by strategic capital raises and refinancing in its Indian subsidiary.

Baumart Holdings has completed a modest capital raise through a rights issue, securing $182,303 before costs, with plans to issue additional shortfall shares to bolster its funding position.

Aspermont has reported a 6% rise in revenue and a 25% jump in net profit for the half year ending March 2025, yet its net tangible assets per share have declined and dividends remain on hold.